Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chromadex Corp CS
(NQ:
CDXC
)
3.340
+0.040 (+1.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chromadex Corp CS
< Previous
1
2
3
4
5
6
Next >
ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)
July 07, 2022
From
ChromaDex Corporation
Via
Business Wire
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
4 Analysts Have This to Say About ChromaDex
June 07, 2022
ChromaDex (NASDAQ:CDXC) has observed the following analyst ratings within the last quarter:
Via
Benzinga
ChromaDex Establishes Joint Venture For Tru Niagen Distribution In China
May 20, 2022
Via
Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
June 23, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
Via
Benzinga
ChromaDex to Present at American Society for Nutrition (ASN), International Society of Sports Nutrition (ISSN), and Federation of American Societies for Experimental Biology (FASEB)
June 15, 2022
From
ChromaDex Corporation
Via
Business Wire
Where ChromaDex Stands With Analysts
May 13, 2022
Within the last quarter, ChromaDex (NASDAQ:CDXC) has observed the following analyst ratings:
Via
Benzinga
Recap: ChromaDex Q4 Earnings
March 09, 2022
ChromaDex (NASDAQ:CDXC) reported its Q4 earnings results on Wednesday, March 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings ChromaDex...
Via
Benzinga
ChromaDex Signs Sinopharm Xingsha Agreement to Accelerate Cross-Border Sales of Tru Niagen® into Mainland China
June 10, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Present at the Oppenheimer’s 22nd Annual Consumer Growth and E-Commerce Conference
June 07, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Partners with Juvenis for Cross-Border Sales of Tru Niagen® into South Korea
June 02, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Present at the LD Micro Invitational
June 01, 2022
From
ChromaDex Corporation
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 20, 2022
Good morning! We're closing in on the end of the week for trading as we go over the biggest pre-market stock movers for Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 19, 2022
Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million.
Via
Benzinga
ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China
May 19, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®
May 17, 2022
From
ChromaDex Corporation
Via
Business Wire
Recap: ChromaDex Q1 Earnings
May 12, 2022
ChromaDex (NASDAQ:CDXC) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings ChromaDex missed estimated earnings...
Via
Benzinga
ChromaDex Corporation Reports First Quarter 2022 Financial Results
May 12, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
April 29, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Appoints Ann Cohen and Kristin Patrick to its Board of Directors
April 22, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex External Research Program (CERP™) Celebrates Over 250 Research Agreements With 235+ Researchers Around the World
April 14, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio
April 06, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Announces Issuance of Additional New U.S. Continuation Patent, Further Protecting Future Innovations
March 16, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex to Report Fourth Quarter 2021 Financial Results on Wednesday, March 9, 2022
February 22, 2022
From
ChromaDex Corporation
Via
Business Wire
Earnings Scheduled For March 9, 2022
March 09, 2022
Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million. • Express (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...
Via
Benzinga
ChromaDex Announces Issuance of New U.S. Continuation Patent, Expanding Intellectual Property Portfolio for Nicotinamide Riboside
February 09, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex External Research Program (CERP™) Celebrates 100 Peer-Reviewed Published Studies on Niagen® and Other Ingredients
January 31, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Announces Results of New Pilot Clinical Trial Showing Anti-Inflammatory Effects of Nicotinamide Riboside (NR) Supplementation
January 25, 2022
From
ChromaDex Corporation
Via
Business Wire
ChromaDex Shares Gain On Niagen Supply Pact With US-Based Provider Of Dietary Supplements
January 20, 2022
ChromaDex Corp (NASDAQ:CDXC) has
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.